$CYTK 4/A SEC Filings

Filed On	Filing
08 Feb 2022	Form 4/A: Henderson John T, Director Received 409 shares as a grant or award ($10K)
08 Apr 2021	Form 4/A: Henderson John T, Director Received 3,333 shares by exercise or conversion ($56.2K) · Gave up 2,684 shares to cover exercise price or tax ($56.2K)
29 Jan 2020	Form 4/A: Califf Robert, Director Granted 4,739 Non-Qualified Stock Option (right to buy) ($50K)
29 Jan 2020	Form 4/A: Henderson John T, Director Granted 9,479 Non-Qualified Stock Option (right to buy) ($100K)
29 Jan 2020	Form 4/A: Kaye Edward M. Md, Director Granted 9,479 Non-Qualified Stock Option (right to buy) ($100K)
29 Jan 2020	Form 4/A: Smith Sandford D, Director Granted 4,739 Non-Qualified Stock Option (right to buy) ($50K)
22 Jan 2016	Form 4/A: Gilbert Denise, Director Acquired 20,000 Stock Option (right to buy) (Other Transaction)
06 Jan 2009	Form 4/A: Spudich James A, Director Granted 17,543 Non-Qualified Stock Option (right to buy) ($20K)
14 Feb 2008	Form 4/A: Schmertzler Michael, Director Granted 10,000 Stock Option (right to buy)
30 Jan 2008	Form 4/A: Heidrich A Grant Iii, Director Granted 10,000 Stock Option (right to buy)
22 Jan 2008	Form 4/A: Spudich James A, Director Granted 10,000 Non-Qualified Stock Option (right to buy)
22 Jan 2008	Form 4/A: Mcdade Mark, Director Granted 10,000 Non-Qualified Stock Option (right to buy)
22 Jan 2008	Form 4/A: Homcy Charles J, Director Granted 10,000 Non-Qualified Stock Option (right to buy)
16 Jan 2008	Form 4/A: Dow Stephen M, Director Granted 10,000 Stock Option (Right To Buy)
26 Jul 2006	Form 4/A: Morgans David J Jr, SVP-Drug Discovery and Dev Exercised 3,490 Incentive Stock Option (right to buy)
26 Jul 2006	Form 4/A: Morgans David J Jr, SVP-Drug Discovery and Dev Exercised 1,510 Incentive Stock Option (right to buy)
14 Nov 2005	Form 4/A: Blum Robert I, EVP, Corp. Development & CBO Exercised 5,000 Non-Qualified Stock Option (right to buy) · Exercised 5,000 Non-Qualified Stock Option (right to buy)

Comments